Sofinnova Partners logo

Sofinnova Partners

Crunchbase
Crunchbase

Deals on record

12

Common Fundraising Type

Series A

nChroma Bio logo
nChroma Bio

Epigenetic editing

Wilson Sonsini Goodrich & Rosati logo
Wellington Management logo
T. Rowe Price logo
Sofinnova Partners logo
Sixth Street logo
Omega Funds logo
Mubadala Capital logo
Menlo Ventures logo

nChroma Bio develops innovative genetic medicines using epigenetic editing and non-viral delivery technologies to treat chronic hepatitis B and D.

Equity
$75M
12/11/2024
Article
Elicit Plant logo
Elicit Plant

Agri-biotech

Elicit Plant is an agri-biotech company that develops phytosterol-based solutions to reduce water usage in broadacre crops by 20%.

Series B
$48M
11/14/2024
Article

Purespring Therapeutics is a gene therapy company specializing in developing treatments for kidney diseases using a proprietary adeno-associated viral (AAV) platform.

Series B
$104.8M
10/09/2024
Article

Arzeda uses AI to design proteins and enzymes for applications in food, home care, and materials.

Equity
$38M
09/17/2024
Article
Novameat logo
Novameat

Sustainable food technology

Sofinnova Partners logo
Unovis Asset Management logo
Rubio Impact Ventures logo
Praesidium logo
Forbion logo

Novameat develops innovative plant-based food products with a unique fibrous texture using proprietary technology to meet the demand for healthier and sustainable food options.

Series A
$19.2M
09/12/2024
Article

Freya Biosciences is a biotech company advancing women's reproductive health through the development of vaginal microbial immunotherapeutics for infertility associated with dysbiotic vaginal microbiota in patients undergoing assisted reproductive technology.

Series A
$38M
12/12/2023
Article

T-Therapeutics is a biotech firm specializing in developing TCR therapeutics for cancer and inflammatory disorders using their proprietary OpTiMus® platform.

Series A
$59.6M
11/16/2023
Article
Betteromics logo
Betteromics

Digital Medicine

Triatomic Capital logo
Sofinnova Partners logo
SHAKTI logo

Betteromics is a digital medicine pioneer that has developed a clinical-grade compliant Software-as-a-Service platform, Omics AI Cloud, which utilizes AI and computational techniques to empower life sciences professionals by eliminating data silos and allowing them to analyze multi-modal, multi-omics data in one place.

Series A
$20M
10/26/2023
Article
L’ecole AI logo
L’ecole AI

AI Technology

Sofinnova Partners logo
Preston-Werner Ventures logo

L'école AI has developed "Machine Teaching" technology that simplifies the engineering complexity of deep-learning systems for computer vision, specifically in the field of image analysis, and aims to enable medical professionals and researchers to create customized AI systems to assist in their respective areas of expertise.

Seed
$3M
10/26/2023
Article
Bon Vivant logo
Bon Vivant

Precision Fermentation

Sofinnova Partners logo
Sparkfood logo
Captech Santé logo
Picus Capital logo
Kima Ventures logo
High Flyers Capital logo
Founders Future logo
Alliance for Impact logo

Bon Vivant is a precision fermentation startup that uses biotech techniques to reprogram yeast microorganisms and produce animal-free milk proteins with a lower environmental footprint, aiming to be a supplier to the food industry rather than a competitor.

Seed
$15.9M
10/12/2023
Article
Sitryx Therapeutics logo
Sitryx Therapeutics

Biopharmaceutical

GSK logo
SV Health Investors logo
Sofinnova Partners logo
Oxford Science Enterprises logo
Longwood Fund logo
Eli Lilly & Company logo

Sitryx Therapeutics is a biopharmaceutical company that develops disease-modifying therapeutics for chronic autoimmune and inflammatory diseases by targeting and regulating cell metabolism.

Equity
$39M
09/27/2023
Article

Gradient Denervation Technologies is a medical device company that develops an ultrasound-based catheter device for the treatment of pulmonary hypertension.

Series A
$15M
09/07/2023
Article